FCF Margin % is calculated as Free Cash Flow divided by its Revenue. NeoGenomics's Free Cash Flow for the
three
months ended in Mar. 2024 was $-31.5 Mil. NeoGenomics's Revenue for the
three
months ended in Mar. 2024 was $156.2 Mil. Therefore, NeoGenomics's FCF Margin % for the quarter that ended in Mar. 2024 was -20.16%.
The historical rank and industry rank for NeoGenomics's FCF Margin % or its related term are showing as below:
NEO'
s FCF Margin % Range Over the Past 10 Years
Min: -19.01 Med: 1.32 Max: 11.01
Current: -6.48
During the past 13 years, the highest FCF Margin % of NeoGenomics was 11.01%. The lowest was -19.01%. And the median was 1.32%.
NEO's FCF Margin % is ranked better than 54.5% of 222
companies
in the Medical Diagnostics & Research industry
Industry Median: -10.405
vs NEO: -6.48
NeoGenomics FCF Margin % Historical Data
The historical data trend for NeoGenomics's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of NeoGenomics's FCF Margin %
For the Diagnostics & Research subindustry, NeoGenomics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeoGenomics's FCF Margin % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, NeoGenomics's FCF Margin % distribution charts can be found below:
* The bar in red indicates where NeoGenomics's FCF Margin % falls into.
NeoGenomics FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
NeoGenomics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeoGenomics FCF Margin % Related Terms
Thank you for viewing the detailed overview of NeoGenomics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NEO has been successfully added to your 